Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Weekly Numbers Update;
sorry all, not in the office till mid next week. Won't be able to update weekly numbers
Conclusion:
Antiinflammatory therapy targeting the interleukin-1ß innate immunity pathway with canakinumab at a dose of 150 mg every 3 months led to a significantly lower rate of recurrent cardiovascular events than placebo, independent of lipid-level lowering.
That says it all, especially what the supposed Dr. Ralphey talked about all of last week
Scripts Update for Week Ending 18/08
ATH across the board in Market Share
2nd ATH across the board in numbers
V
TRx: 24,088 {vs 23,818; +1.13%} Sector -0.87% -- 2nd ATH
NRx: 9,433 {vs 9,239; +2.10%} Sector -0.65% -- 2nd ATH
Ref: 14,655 {vs 14,579; +0.52%} Sector -1.00% -- 2nd ATH
GenL
TRx: 50,566 {vs 51,438; -1.70%}
NRx: 18,656 {vs 19,053; -2.08%}
L
TRx: 4,533 {vs 4,625; -1.99%}
NRx: 1,943 {vs 1,935; +0.41%}
V TRx Market Share: 30.42% vs 29.82% -- ATH
V NRx Market Share: 31.41% vs 30.57% -- ATH
V Ref Market Share: 29.81% vs 29.36% -- ATH
July-2017 vs. July-2016 (Retail + Inst Data)
V
TRx: 107,826 {vs 75,220; +43.35%} – Sector +1.42% -- ATH
NRx: 38,222 {vs 27,348; +39.76%} – Sector +2.21% -- ATH
Ref: 69,604 {vs 47,872; +45.40%} – Sector +1.02% -- ATH
Gen L
TRx: 254,398 {vs 281,824; -9.73%}
NRx: 83,340 {vs 92,060; -9.47%}
L
TRx: 11,888 {vs 11,833; +0.46%}
NRx: 4,240 {vs 3,675; +15.37%}
V July-2017 Retail + Inst TRx Market Share: 28.82% vs 20.39% in July-2016 -- ATH
V July-2017 Retail + Inst NRx Market Share: 30.39% vs 22.22% in July-2016 -- ATH
V July-2017 Retail + Inst Ref Market Share: 28.03% vs 19.48% in July-2016 -- ATH
Total Monthly Retail + Institutional Data July-2017
GREAT INSTITUTIONAL NUMBERS. LARGE ESTABLISHMENTS (ie Hospitals, Clinics…etc) FINALLY TAKING NOTICE
V
TRx: 107,826 {vs 104,324; +3.36%} -- Sector +1.69% --- ATH
(Inst # 7,156 vs 5,254; +36.20% -- ATH -- Inst Sec +13.30% -- Inst Mkt Sh 21.41% vs 17.81% ATH)
NRx: 38,222 {vs 39,078; -2.19%} – Sector -2.15% -- 4th ATH
Ref: 69,604 {vs 65,246; +6.68%} – Sector +3.75% -- ATH
Gen L
TRx: 254,398 {vs 256,738; -0.91%}
(Inst # 25,398 vs 23,378; +8.64%)
NRx: 83,340 {vs 87,540; -4.80%}
L
TRx: 11,888 {vs 6,842; +73.75%}
(Inst # 875 vs 872; +0.34%)
NRx: 4,240 {vs 1,950; +117.44%}
V Monthly Retail + Inst. TRx Market Share: 28.82% vs 28.36% --- ATH
V Monthly Retail + Inst. NRx Market Share: 30.39% vs 30.39% --- = to ATH
V Monthly Retail + Inst. Ref Market Share: 28.03% vs 27.26% --- ATH
NB: As per Symphony Health Solution Description once the new Data Method started, the definition of Institutional is:
"Institutional Sales Channels: Drug Sales into Hospitals, Doctor’s Offices, Dialysis Clinics, Long-Term Health Facilities, Prisons"
Scripts Update for Week Ending 11/08
V
TRx: 23,818 {vs 23,952; -0.56%} Sector +0.06%
NRx: 9,239 {vs 9,471; -2.45%} Sector +0.10%
Ref: 14,579 {vs 14,481; +0.68%} Sector +0.03%
GenL
TRx: 51,438 {vs 51,380; +0.11%}
NRx: 19,053 {vs 18,846; +1.10%}
L
TRx: 4,625 {vs 4,502; +2.73%}
NRx: 1,935 {vs 1,880; +2.93%}
V TRx Market Share: 29.82% vs 30.00%
V NRx Market Share: 30.57% vs 30.36%
V Ref Market Share: 29.36% vs 29.17%
Total Monthly Retail ONLY Data July-2017
ATH Across the Board in Market Share & Number (except NRx Numbers)
V
TRx: 100,670 {vs 99,070; +1.62%} – Sector +0.67% -- ATH
NRx: 38,222 {vs 39,078; -2.19%} – Sector -2.15% -- 4th ATH
Ref: 62,448 {vs 59,992; +4.09%} – Sector +2.41% -- ATH
Gen L
TRx: 229,000 {vs 233,360; -1.87%}
NRx: 83,340 {vs 87,540; -4.80%}
L
TRx: 11,013 {vs 5,970; +84.47%}
NRx: 4,240 {vs 1,950; +117.44%}
Monthly Retail TRx Market Share: 29.55% vs 29.28% --- ATH
Monthly Retail NRx Market Share: 30.39% vs 30.39% --- = to ATH
Monthly Retail Refills Market Share: 29.06% vs 28.59% --- ATH
Could,
it didn't go back to normal. Last week's L numbers were confirmed in today's number
Thanks Merc & AV
Important Question...Help Needed
Can you please let me know if NEPTUNE KRILL OIL is FDA approved, is it being sold via medical prescription or OTC ??
The reason i am asking is that i ran through a stand selling Neptune Krill Oil (Omega 3 / Astaxanthin - Choline) and i thought it is not yet approved ... Your help is needed so i know how to follow on this with relevant government agencies in my country.
PS:Label says "Manufactured by Neptune inder GMP Guidelines for Best Health" & " made in Canada"
Scripts Update for Week Ending 04/08
ATH in NRx for V, 2nd ATH in TRx & Refills
GL NRx is lowest since Nov-2014 for a full week (except those random short holiday numbers)
GL TRx is lowest since Jan-2015 for a full week (except those random short holiday numbers)
L TRx highest since Aug-2015 & NRx highest since Apr-2015 --- Really weird !!!
V
TRx: 23,952 {vs 23,557; +1.68%} Sector +0.69% -- 2nd ATH
NRx: 9,471 {vs 9,104; +4.03%} Sector +0.15% -- ATH
Ref: 14,481 {vs 14,453; +0.19%} Sector +1.02% -- 2nd ATH
GenL
TRx: 51,380 {vs 51,215; +0.32%}
NRx: 18,846 {vs 19,169; -1.69%}
L
TRx: 4,502 {vs 4,518; -0.35%}
NRx: 1,880 {vs 1,880; +0.00%}
V TRx Market Share: 30.00% vs 29.71% -- 2nd ATH
V NRx Market Share: 31.36% vs 30.19% -- ATH
V Ref Market Share: 29.17% vs 29.41% -- 3rd ATH
VN,
I thought already of what you said, but if true, the result will be that Total TRx Market will be down by 5% and historically, during this period that never happened
Scripts Update for Week Ending 28/07
Really Odd numbers for Lovaza – Will keep on checking if it will be amended later on
V
TRx: 23,557 {vs 24,143; -2.43%} Sector -0.86% -- 2nd ATH
NRx: 9,104 {vs 9,335; -2.47%} Sector -0.17% -- 6th ATH
Ref: 14,453 {vs 14,808; -2.40%} Sector -1.28% -- 2nd ATH
GenL
TRx: 51,215 {vs 54,502; -6.03%}
NRx: 19,169 {vs 20,405; -6.06%}
L WTF is happening with L & GL
TRx: 4,518 {vs 1,333; +238.93%}
NRx: 1,880 {vs 464; +305.17%}
V TRx Market Share: 29.71% vs 30.19% -- 2nd ATH
V NRx Market Share: 30.19% vs 30.91% -- 6th ATH
V Ref Market Share: 29.41% vs 29.75% -- 2nd ATH
Raf,
I've never mentioned where i am from and most def i ain't from where you said :):)
Scripts Update for Week Ending 21/07
TRx > 24K -- ATH Across the Board
V
TRx: 24,143 {vs 23,141; +4.33%} Sector +1.39% -- ATH
NRx: 9,335 {vs 9,246; +0.96%} Sector +0.41% -- ATH
Ref: 14,808 {vs 13,895; +6.57%} Sector +2.00% -- ATH
GenL
TRx: 54,502 {vs 54,371; +0.24%}
NRx: 20,405 {vs 20,408; -0.01%}
L
TRx: 1,333 {vs 1,368; -2.56%}
NRx: 464 {vs 426; +8.92%}
V TRx Market Share: 30.19% vs 29.34% -- ATH
V NRx Market Share: 30.91% vs 30.74% -- {2nd ATH}
V Ref Market Share: 29.75% vs 28.47% -- ATH
Raf,
HD will be way more helpful in this, but using those numbers and x by selling price, taking ~ 76% gross margin will get you a number from which you subtracts r&d, salaries....etc
or using the 76% includes the cost....etc??
See, that's why HD is the master in these stuff :):)
I guess they will be beating their estimate
Raf,
I would make my calculation in another way;
Q1+Q2 2017 = 569,986 (Avg 21,923 for 26 Weeks)
Q3+Q4 with the same % increase of 22.49% will = 698,176 ( Avg 26,853)
My previous numbers were taken from the weekly numbers not monthly....The above is more accurate i would say
Raf; RE: Your Questions
Sorry quite busy, but i just checked the numbers quickly and i can answer some questions;
1) How many scripts are we averaging weekly this year?
28 Weeks available Data, Total TRx 591,371 --> Avg Weekly = 21,120
Total NRx 239,489 --> Avg Weekly = 8,553
4) how did we do in scripts last year second half vs the first half?
H2-2016 vs H1-2016
TRx: +22.49%
NRx: +19.58%
Ref: +24.27%
Scripts Update for Week Ending 14/07
ATH for TRx & NRx
V
TRx: 23,141 {vs 21,589; +7.19%} Sector +6.22% -- ATH
NRx: 9,246 {vs 7,668; +20.58%} Sector +16.19% -- ATH
Ref: 13,895 {vs 13,921; -0.19%} Sector +0.88%
GenL
TRx: 54,371 {vs 51,311; +5.96%}
NRx: 20,408 {vs 17,766; +14.87%}
L
TRx: 1,368 {vs 1,363; +0.37%}
NRx: 426 {vs 454; -6.17%}
V TRx Market Share: 29.34% vs 29.07% -- 4th ATH
V NRx Market Share: 30.74% vs 29.62% -- 2nd ATH
V Ref Market Share: 28.47% vs 28.78% -- 5th ATH
H1-2017 vs. H1-2016 (Retail + Institutional Data)
V
TRx H1-2017 vs H1-2016 +41.58% – Sector -3.42%
NRx H1-2017 vs H1-2016 +45.18% – Sector +0.07%
Ref H1-2017 vs H1-2016 +39.38% – Sector -5.25%
Gen L
TRx H1-2017 vs H1-2016 -10.58%
NRx H1-2017 vs H1-2016 -9.74%
L
TRx H1-2017 vs H1-2016 -57.54%
NRx H1-2017 vs H1-2016 -44.61%
V H1-2017 Retail + Institutional TRx Market Share: 26.41% vs 18.01% in H1-2016 --- ATH
V H1-2017 Retail + Institutional NRx Market Share: 28.83% vs 19.87% in H1-2016 --- ATH
V H1-2017 Retail + Institutional Ref Market Share: 25.07% vs 17.04% in H1-2016 --- ATH
Q2-2017 vs. Q2-2016 (Retail + Institutional Data)
V
TRx: 301,546 {vs 215,355; +40.02%} – Sector -3.26% --- ATH
NRx: 113,911 {vs 80,275; +41.90%} – Sector +0.58% --- ATH
Ref: 187,635 {vs 135,080; +38.91%} – Sector -5.21% --- ATH
Gen L
TRx: 764,592 {vs 863,196; -11.42%}
NRx: 261,672 {vs 288,100; -9.17%}
L
TRx: 20,805 {vs 44,965; -53.73%}
NRx: 6,158 {vs 11,159; -44.82%}
V Q2-2017 Retail + Institutional TRx Market Share: 27.74% vs 19.17% in Q2-2016 -- ATH
V Q2-2017 Retail + Institutional NRx Market Share: 29.84% vs 21.15% in Q2-2016 – ATH
V Q2-2017 Retail + Institutional Ref Market Share: 26.61% vs 18.16% in Q2-2016 – ATH
Q2-2017 vs. Q1-2017 (Retail + Institutional Data)
V
TRx: 301,546 {vs 268,440; +12.33%} – Sector +1.44% --- ATH
NRx: 113,911 {vs 107,921; +5.55%} – Sector -1.55% --- ATH
Ref: 187,635 {vs 160,519; +16.89%} – Sector +3.13% --- ATH
Gen L
TRx: 764,592 {vs 778,660; -1.81%}
NRx: 261,672 {vs 272,515; -3.98%}
L
TRx: 20,805 {vs 24.453; -14.92%}
NRx: 6,158 {vs 7,325; -15.93%}
V Q2-2017 Retail + Institutional TRx Market Share: 27.74% vs 25.05% in Q1-2017 -- ATH
V Q2-2017 Retail + Institutional NRx Market Share: 29.84% vs 27.83% in Q1-2017 – ATH
V Q2-2017 Retail + Institutional Ref Market Share: 26.61% vs 23.47% in Q1-2017 – ATH
Total Monthly Retail + Institutional Data June-2017
V
TRx: 104,324 {vs 103,700; +0.60%} -- Sector -1.51% --- ATH
(Inst # 5,254 vs 5,303; -0.92%)
NRx: 39,078 {vs 38,785; +0.76%} – Sector -1.60% -- 2nd ATH
Ref: 65,246 {vs 64,915; +0.51%} – Sector -1.47% -- ATH
Gen L
TRx: 256,738 {vs 262,671; -2.26%}
(Inst # 23,378 vs 22,201; +5.30%)
NRx: 87,540 {vs 89,759; -2.47%}
L
TRx: 6,842 {vs 7,181; -4.72%}
(Inst # 872 vs 961; -9.26%)
NRx: 1,950 {vs 2,111; -7.63%}
V Monthly Retail + Inst. TRx Market Share: 28.36% vs 27.76% --- ATH
V Monthly Retail + Inst. NRx Market Share: 30.39% vs 29.69% --- ATH
V Monthly Retail + Inst. Ref Market Share: 27.26% vs 26.73% --- ATH
Scripts Update for Week Ending 07/07
Short Week due to 4th of July
V
TRx: 21,589 {vs 22,889; -5.68%} Sector -4.35%
NRx: 7,668 {vs 9,125; -15.97%} Sector -11.24%
Ref: 13,921 {vs 13,764; +1.14%} Sector -0.21%
GenL
TRx: 51,311 {vs 53,301; -3.73%}
NRx: 17,766 {vs 19,570; -9.22%}
L
TRx: 1,363 {vs 1,452; -6.13%}
NRx: 454 {vs 470; -3.40%}
V TRx Market Share: 29.07% vs 29.48%
V NRx Market Share: 29.62% vs 31.29%
V Ref Market Share: 28.78% vs 28.39%
Raf,
I will call you with 4-5 suited and draw the luckiest turn & river for flush after calling your all in :):)
hahahah
H1-2017 vs. H1-2016 (Retail only Data)
V
TRx H1-2017 vs H1-2016 +44.82% – Sector -0.91%
NRx H1-2017 vs H1-2016 +45.18% – Sector +0.07%
Ref H1-2017 vs H1-2016 +44.57% – Sector -1.51%
Gen L
TRx H1-2017 vs H1-2016 -9.87%
NRx H1-2017 vs H1-2016 -9.74%
L
TRx H1-2017 vs H1-2016 -44.97%
NRx H1-2017 vs H1-2016 -44.61%
V H1-2017 Retail Only TRx Market Share: 27.28% vs 18.67% in H1-2016 -- ATH in terms of Half year comparison
V H1-2017 Retail Only NRx Market Share: 28.83% vs 19.87% in H1-2016 -- ATH in terms of Half year comparison
V H1-2017 Retail Only Ref Market Share: 26.31% vs 17.92% in H1-2016 -- ATH in terms of Half year comparison
Q2-2017 vs. Q1-2017 (Retail ONLY Data)
V
TRx: 287,124 {vs 257,422; +11.54%} – Sector +1.26% --- ATH
NRx: 113,911 {vs 107,921; +5.55%} – Sector -1.55% --- ATH
NRx: 173,213 {vs 149,201; +15.86%} – Sector +3.06% --- ATH
Gen L
TRx: 698,830 {vs 713,250; -2.02%}
NRx: 261,672 {vs 272,515; -3.98%}
L
TRx: 18,262 {vs 21,057; -13.27%}
NRx: 6,158 {vs 7,325; -15.93%}
V Q2-2017 Retail ONLY TRx Market Share: 28.59% vs 25.96% in Q1-2017 – ATH
V Q2-2017 Retail ONLY NRx Market Share: 29.84% vs 27.83% in Q1-2017 -- ATH
V Q2-2017 Retail ONLY Ref Market Share: 27.83% vs 24.75% in Q1-2017 -- ATH
Q2-2017 vs. Q2-2016 (Retail ONLY Data)
V
TRx: 287,124 {vs 200,804; +42.99%} – Sector -0.94% --- ATH
NRx: 113,911 {vs 80,275; +41.90%} – Sector +0.58% --- ATH
Ref: 173,213 {vs 120,529; +43.71%} – Sector -1.85% --- ATH
Gen L
TRx: 698,830 {vs 780,280; -10.44%}
NRx: 261,672 {vs 288,100; -9.17%}
L
TRx: 18,262 {vs 32,666; -44.09%}
NRx: 6,158 {vs 11,159; -44.82%}
V Q2-2017 Retail ONLY TRx Market Share: 28.59% vs 19.81% in Q2-2016 -- ATH
V Q2-2017 Retail ONLY NRx Market Share: 29.84% vs 21.15% in Q2-2016 -- ATH
V Q2-2017 Retail ONLY Ref Market Share: 27.83% vs 19.00% in Q2-2016 -- ATH
Total Monthly Retail ONLY Data June-2017
ATH Across the Board in Market Share & Numbers (except NRx)
V
TRx: 99,070 {vs 98,397; +0.68%} – Sector -1.94% -- ATH
NRx: 39,078 {vs 38,785; +0.76%} – Sector -1.60% -- 2nd ATH
Ref: 59,992 {vs 59,612; +0.64%} – Sector -2.15% -- ATH
Gen L
TRx: 233,360 {vs 240,470; -2.96%}
NRx: 87,540 {vs 89,759; -2.47%}
L
TRx: 5,970 {vs 6,220; -4.02%}
NRx: 1,950 {vs 2,111; -7.63%}
Monthly Retail TRx Market Share: 29.28% vs 28.51% --- ATH
Monthly Retail NRx Market Share: 30.39% vs 29.69% --- ATH
Monthly Retail Refills Market Share: 28.59% vs 27.80% -- ATH
Scripts Update for Week Ending 30/06
Sorry for the delay :)
V
TRx: 22,889 {vs 22,521; +1.63%} Sector +1.34% -- {2nd ATH}
NRx: 9,125 {vs 8,811; +3.56%} Sector -0.05% -- {3rd ATH}
Ref: 13,764 {vs 13,710; +0.39%} Sector +2.20% -- {2nd ATH}
GenL
TRx: 53,301 {vs 52,816; +0.92%}
NRx: 19,570 {vs 19,962; -1.96%}
L
TRx: 1,452 {vs 1,279; +13.53%}
NRx: 470 {vs 408; +15.20%}
V TRx Market Share: 29.48% vs 29.39% -- ATH
V NRx Market Share: 31.29% vs 30.19% -- ATH
V Ref Market Share: 28.39% vs 28.90% -- {4th ATH}
Sorry all, I must be present at a conference all day tmw and won't be able to update the scripts
Scripts Update for Week Ending 23/06
V
TRx: 22,521 {vs 22,756; -1.03%} Sector -0.88%
NRx: 8,811 {vs 8,952; -1.58%} Sector -0.64%
Ref: 13,710 {vs 13,804; -0.68%} Sector -1.02%
GenL
TRx: 52,816 {vs 53,213; -0.75%}
NRx: 19,962 {vs 19,987; -0.13%}
L
TRx: 1,279 {vs 1,325; -3.47%}
NRx: 408 {vs 431; -5.34%}
V TRx Market Share: 29.39% vs 29.44% -- {2nd ATH}
V NRx Market Share: 30.19% vs 30.48% -- {3rd ATH}
V Ref Market Share: 28.90% vs 28.80% -- ATH
JL,
Purr will pop up and say he triple shorted @ 4.1 and this way was able to close all his position with a nice profit :):):(
Raf,
If i remember well, the prices you mentioned $2 & $17 were for a bear case scenario (Red-it Failure) & Bull Case (Success of Red-it + label expansion + sales increase for 70M population EXCLUDING any further foreign deals).
The $7 new PT is for a 55% Red-it Success EXCLUDING foreign deals.
Open for ideas if the above ain't accurate
Scripts Update for Week Ending 16/06
ATH Across the Board in Market Share
V
TRx: 22,756 {vs 23,089; -1.44%} Sector -2.79% -- {2nd ATH}
NRx: 8,952 {vs 8,912; +0.45%} Sector -1.98% -- {5th ATH}
Ref: 13,804 {vs 14,177; -2.63%} Sector -3.28% -- {2nd ATH}
GenL
TRx: 53,213 {vs 55,032; -3.31%}
NRx: 19,987 {vs 20,584; -2.90%}
L
TRx: 1,325 {vs 1,393; -4.88%}
NRx: 431 {vs 467; -7.71%}
V TRx Market Share: 29.44% vs 29.04% -- ATH
V NRx Market Share: 30.48% vs 29.74% -- ATH
V Ref Market Share: 28.80% vs 28.61% -- ATH
QUICK SUMMARY (2)
My bad guys, turned out i mixed the old numbers. Q2-2016 stands at 215,335 not 191,860
Sorry for that and Thank you HDGabor for pointing that out of ST
Quick Summary
For those interested, Q2-2017 vs Q2-2016
In just 2 month (i.e April & May 2017) Total TRx > Full Q2-2016
As we stand currently;
TRx (April & May 2017) = 197,222
VS.
TRx (Q2-2016 Apr+May+June) = 191,860
If June Monthly Numbers are just as May Numbers, well Q2 will have a growth of ~55% compared to Q2 2016
Long & Strong :):)
Total Monthly Retail + Institutional Data May-2017
ATH ACROSS THE BOARD; Numbers & Market Share
TRx > 100K per month
V
TRx: 103,700 {vs 93,522; +10.88%} -- Sector +8.12% --- ATH
(Inst # 5,303 vs 3,865; +37.21% -- ATH -- Inst. Sector +14.97% -- Inst Mkt Share: 18.63% vs 15.61% -- ATH)
NRx: 38,785 {vs 36,048; +7.59%} – Sector +6.64% -- 2nd ATH
Ref: 64,915 {vs 57,474; +12.95%} – Sector +8.94% -- ATH
Gen L
TRx: 262,671 {vs 245,183; +7.13%}
(Inst # 22,201 vs 20,210; +10.00%)
NRx: 89,759 {vs 84,373; +6.38%}
L
TRx: 7,181 {vs 6,782; +5.88%}
(Inst # 961 vs 710; +35.35%)
NRx: 2,111 {vs 2,097; +0.67%}
V Monthly Retail + Inst. TRx Market Share: 27.76% vs 27.07% --- ATH
V Monthly Retail + Inst. NRx Market Share: 29.69% vs 29.42% --- ATH
V Monthly Retail + Inst. Ref Market Share: 26.73% vs 25.78% --- ATH
Scripts Update for Week Ending 09/06
ATH in TRx & Refills Numbers & Market Share
NRx Numbers & Market Share is 5th ATH
V
TRx: 23,089 {vs 20,962; +10.15%} Sector +6.63% -- ATH
NRx: 8,912 {vs 7,808; +14.14%} Sector +12.72%
Ref: 14,177 {vs 13,154; +7.78%} Sector +3.26% -- ATH
GenL
TRx: 55,032 {vs 52,169; +5.49%}
NRx: 20,584 {vs 18,292; +12.53%}
L
TRx: 1,393 {vs 1,436; -2.99%}
NRx: 467 {vs 482; -3.11%}
V TRx Market Share: 29.04% vs 28.11% -- ATH
V NRx Market Share: 29.74% vs 29.37% -- {ATH = 30.22%}
V Ref Market Share: 28.61% vs 27.41% -- ATH
Total Monthly Retail ONLY Data May-2017
ATH Across the Board in Market Share & Number (Except in NRx = 2nd ATH)
V
TRx: 98,397 {vs 89,657; +9.75%} – Sector +7.59% -- ATH
NRx: 38,785 {vs 36,048; +7.59%} – Sector +6.64% -- 2nd ATH
Ref: 59,612 {vs 53,609; +11.20%} – Sector +8.18% -- ATH
Gen L
TRx: 240,470 {vs 225,000; +6.88%}
NRx: 89,759 {vs 84,373; +6.38%}
L
TRx: 6,220 {vs 6,072; +2.44%}
NRx: 2,111 {vs 2,097; +0.67%}
Monthly Retail TRx Market Share: 28.51% vs 27.95% --- ATH
Monthly Retail NRx Market Share: 29.69% vs 29.42% --- ATH
Monthly Retail Refills Market Share: 27.80% vs 27.05% --- ATH